CN101027410A - 用于癌症诊断的寡核苷酸 - Google Patents

用于癌症诊断的寡核苷酸 Download PDF

Info

Publication number
CN101027410A
CN101027410A CN200580026265.8A CN200580026265A CN101027410A CN 101027410 A CN101027410 A CN 101027410A CN 200580026265 A CN200580026265 A CN 200580026265A CN 101027410 A CN101027410 A CN 101027410A
Authority
CN
China
Prior art keywords
gene
oligonucleotide
sample
cancer
probe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200580026265.8A
Other languages
English (en)
Chinese (zh)
Inventor
普拉维恩·沙玛
安德斯·郎内博格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagenic AS
Original Assignee
Diagenic AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagenic AS filed Critical Diagenic AS
Publication of CN101027410A publication Critical patent/CN101027410A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CN200580026265.8A 2004-06-02 2005-06-02 用于癌症诊断的寡核苷酸 Pending CN101027410A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0412301.4A GB0412301D0 (en) 2004-06-02 2004-06-02 Product and method
GB0412301.4 2004-06-02

Publications (1)

Publication Number Publication Date
CN101027410A true CN101027410A (zh) 2007-08-29

Family

ID=32696533

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200580026265.8A Pending CN101027410A (zh) 2004-06-02 2005-06-02 用于癌症诊断的寡核苷酸

Country Status (17)

Country Link
US (2) US8105773B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1766056B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP5060945B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN101027410A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AP (1) AP2006003862A0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE493511T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2005250219B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2568889A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE602005025633D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK1766056T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2358910T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB0412301D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NO (1) NO20065939L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ551797A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SI (1) SI1766056T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2005118851A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200610644B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104822844A (zh) * 2012-10-01 2015-08-05 米伦纽姆医药公司 预测对抑制剂的反应的生物标记物和方法以及其用途
CN109529018A (zh) * 2019-01-10 2019-03-29 南方医科大学南方医院 Atxn2l用于制备逆转胃癌奥沙利铂耐药的药物的用途
CN110444287A (zh) * 2011-04-29 2019-11-12 癌症预防和治疗有限公司 使用分类系统及其试剂盒识别和诊断肺部疾病的方法
CN111910002A (zh) * 2014-06-18 2020-11-10 东丽株式会社 食道癌的检测试剂盒或装置以及检测方法
CN113913436A (zh) * 2021-11-18 2022-01-11 天津市肿瘤医院(天津医科大学肿瘤医院) 逆转录转座基因l1-atp8b1及其作为肺鳞癌标志物的用途和治疗肺鳞癌的药物
CN115976212A (zh) * 2022-12-21 2023-04-18 四川大学华西医院 一种用于检测骨肿瘤诊断相关基因的探针库及试剂盒

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006128082A2 (en) * 2005-05-26 2006-11-30 The Johns Hopkins University Biomarkers for breast cancer
JP2007275027A (ja) * 2006-04-12 2007-10-25 Fujifilm Corp 癌関連欠失遺伝子マーカーを用いた癌の診断方法
JP5208477B2 (ja) * 2007-10-12 2013-06-12 生化学工業株式会社 遺伝子サブトラクション用の担体及びその利用
JP2013511728A (ja) * 2009-11-20 2013-04-04 ユニバーシティ オブ ルイスビル リサーチ ファンデーション,インコーポレイテッド 癌のバイオマーカー
GB201000688D0 (en) * 2010-01-15 2010-03-03 Diagenic Asa Product and method
EP2922971B1 (en) * 2012-11-20 2018-10-17 Lund, Tore Eiliv Gene expression profile in diagnostics
CA2935232A1 (en) 2013-12-29 2015-07-02 Curelab Oncology, Inc. Methods and compositions relating to p62/sqstm1 for the treatment and prevention of inflammation-associated diseases
FR3029210A1 (fr) 2014-11-27 2016-06-03 Centre Nat De La Rech Scient (Cnrs) Methode de pronostic d'hemopathies
US10140708B2 (en) * 2016-01-21 2018-11-27 Riverside Research Institute Method for gestational age estimation and embryonic mutant detection
GB201611738D0 (en) 2016-07-05 2016-08-17 Cambridge Entpr Ltd Biomarkers for inflammatory bowel disease
WO2019036388A1 (en) * 2017-08-14 2019-02-21 Raytheon Company ALGORITHM OF SUBTRACTION FOR DETECTION OF TUMORS
CN109596611A (zh) * 2019-01-21 2019-04-09 湖北紫荆生物技术有限公司 一种水体钙含量测试剂及水体钙含量测量方法
US11475558B2 (en) 2019-11-13 2022-10-18 Raytheon Company Organ isolation in scan data
US11282209B2 (en) 2020-01-10 2022-03-22 Raytheon Company System and method for generating contours
US11893745B2 (en) 2020-12-09 2024-02-06 Raytheon Company System and method for generating and displaying contours
US11562512B2 (en) 2020-12-09 2023-01-24 Raytheon Company System and method for generating and displaying contours

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981783A (en) * 1986-04-16 1991-01-01 Montefiore Medical Center Method for detecting pathological conditions
US5925525A (en) * 1989-06-07 1999-07-20 Affymetrix, Inc. Method of identifying nucleotide differences
US5800992A (en) * 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5871928A (en) * 1989-06-07 1999-02-16 Fodor; Stephen P. A. Methods for nucleic acid analysis
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
JP2802125B2 (ja) 1989-06-23 1998-09-24 キヤノン株式会社 核酸の検出方法
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
ATE143700T1 (de) 1991-09-23 1996-10-15 Pfizer Verfahren für die detektion von spezifische mrns und dns in zellen
GB2260811B (en) 1991-10-23 1995-07-05 Yorkshire Cancer Research Camp Detection of malignant tumours
WO1993018143A1 (en) 1992-03-04 1993-09-16 Synaptic Pharmaceutical Corporation Dna encoding taurine and gaba transporters and uses thereof
US6114114A (en) 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
US5633137A (en) * 1992-12-01 1997-05-27 The University Of South Florida Method for measuring specific gene expression: transcriptional activity per gene dose
US5677125A (en) * 1994-01-14 1997-10-14 Vanderbilt University Method of detection and diagnosis of pre-invasive cancer
US5830645A (en) * 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5545531A (en) * 1995-06-07 1996-08-13 Affymax Technologies N.V. Methods for making a device for concurrently processing multiple biological chip assays
US6156502A (en) 1995-12-21 2000-12-05 Beattie; Kenneth Loren Arbitrary sequence oligonucleotide fingerprinting
AU2253397A (en) 1996-01-23 1997-08-20 Affymetrix, Inc. Nucleic acid analysis techniques
JP2000504575A (ja) 1996-02-08 2000-04-18 アフィメトリックス,インコーポレイテッド 微生物のチップベースの種分化および表現型特徴付け
AU4327697A (en) 1996-08-20 1998-03-06 Motorola, Inc. Method and apparatus for detecting predetermined molecular structures in a sample
US6235474B1 (en) 1996-12-30 2001-05-22 The Johns Hopkins University Methods and kits for diagnosing and determination of the predisposition for diseases
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US5994076A (en) * 1997-05-21 1999-11-30 Clontech Laboratories, Inc. Methods of assaying differential expression
AU9071098A (en) 1997-07-29 1999-02-22 Lambert C. J. Dorssers Breast cancer resistance genes, methods for their detection and uses thereof
US6607879B1 (en) * 1998-02-09 2003-08-19 Incyte Corporation Compositions for the detection of blood cell and immunological response gene expression
US6174680B1 (en) * 1998-12-30 2001-01-16 Dana-Farber Cancer Institute, Inc. Method for identifying mismatch repair glycosylase reactive sites, compounds and uses thereof
ATE347102T1 (de) 1998-02-25 2006-12-15 Us Health Zellulare anordnungen für schnelle molekulare profilidentifizierung
US6004755A (en) * 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
US6696246B1 (en) 1998-08-21 2004-02-24 Naxcor, Inc. Assays using crosslinkable immobilized nucleic acids
US20080261292A1 (en) * 1998-09-22 2008-10-23 Oncomedx, Inc. Method Enabling the Use of Extracellular Ribonucleic Acid (RNA) Extracted from Plasma or Serum to Detect, Monitor or Evaluate Cancer or Premalignant Conditions
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
EP1121471A1 (en) 1998-10-13 2001-08-08 Clontech Laboratories, Inc. Nucleic acid arrays
EP1131470A4 (en) 1998-10-28 2004-11-10 Vysis Inc CELLULAR NETWORKS AND METHODS FOR DETECTION AND USE OF GENETIC DISORDER MARKERS
WO2000026412A1 (en) 1998-11-02 2000-05-11 Kenneth Loren Beattie Nucleic acid analysis using sequence-targeted tandem hybridization
AU1853600A (en) 1999-01-06 2000-07-24 Choong-Chin Liew Method for the detection of gene transcripts in blood and uses thereof
US20040241728A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of lung disease related gene transcripts in blood
US7473528B2 (en) * 1999-01-06 2009-01-06 Genenews Inc. Method for the detection of Chagas disease related gene transcripts in blood
US20050123938A1 (en) 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20050003394A1 (en) * 1999-01-06 2005-01-06 Chondrogene Limited Method for the detection of rheumatoid arthritis related gene transcripts in blood
US20040248169A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of obesity related gene transcripts in blood
US20040265868A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of depression related gene transcripts in blood
US20040265869A1 (en) * 1999-01-06 2004-12-30 Chondrogene Limited Method for the detection of type II diabetes related gene transcripts in blood
US20040241727A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of schizophrenia related gene transcripts in blood
US20050042630A1 (en) * 1999-01-06 2005-02-24 Chondrogene Limited Method for the detection of asthma related gene transcripts in blood
US20040241726A1 (en) * 1999-01-06 2004-12-02 Chondrogene Limited Method for the detection of allergies related gene transcripts in blood
US20040248170A1 (en) * 1999-01-06 2004-12-09 Chondrogene Limited Method for the detection of hyperlipidemia related gene transcripts in blood
DE19937187A1 (de) * 1999-08-06 2001-03-01 Qiagen Gmbh Automatisierte Proteinreinigung im Multiwellformat durch Vakuumfiltration
WO2002008765A2 (en) * 2000-07-26 2002-01-31 Stanford University Basal cell markers in breast cancer and uses thereof
US7108969B1 (en) * 2000-09-08 2006-09-19 Affymetrix, Inc. Methods for detecting and diagnosing oral cancer
US6955876B2 (en) * 2000-11-01 2005-10-18 Kane Michael D Compositions and systems for identifying and comparing expressed genes (mRNAs) in eukaryotic organisms
WO2002059367A2 (en) 2000-11-30 2002-08-01 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis
JP4368110B2 (ja) * 2001-01-12 2009-11-18 エール ユニヴァーシティ 癌患者の生物学的流体中のサバイビンの検出
US20020132274A1 (en) * 2001-01-17 2002-09-19 Nevalainen Marja T. Diagnostic and monitorings methods for cancer
AU2002253878A1 (en) * 2001-01-25 2002-08-06 Gene Logic, Inc. Gene expression profiles in breast tissue
WO2002070737A2 (en) 2001-02-28 2002-09-12 Chondrogene Inc. Compositions and methods relating to osteoarthritis
EP1384079A2 (en) * 2001-05-02 2004-01-28 Oxford GlycoSciences (UK) Limited Proteins, genes and their use for diagnosis and treatment of breast cancer
US20020169560A1 (en) * 2001-05-12 2002-11-14 X-Mine Analysis mechanism for genetic data
US7335467B2 (en) * 2001-05-15 2008-02-26 Ludwig Institute For Cancer Research Breast cancer antigens
US20030036077A1 (en) * 2001-05-31 2003-02-20 Chronix Biomedical Methods for generating an mRNA expression profile from an ecellular mRNA containing blood sample and using the same to identify functional state markers
US7297480B2 (en) * 2001-06-28 2007-11-20 Dermtech International Method for detection of melanoma
WO2003008963A1 (en) * 2001-07-18 2003-01-30 University Of Louisville Research Foundation, Inc. E-genechip online web service for data mining bioinformatics
US7229774B2 (en) * 2001-08-02 2007-06-12 Regents Of The University Of Michigan Expression profile of prostate cancer
US7622260B2 (en) * 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests
CA2466483A1 (en) * 2001-11-07 2003-07-03 John D. Shaughnessy Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling
US7371736B2 (en) * 2001-11-07 2008-05-13 The Board Of Trustees Of The University Of Arkansas Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
US20030232350A1 (en) * 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
WO2003041562A2 (en) * 2001-11-14 2003-05-22 Whitehead Institute For Biomedical Research Molecular cancer diagnosis using tumor gene expression signature
AU2002361908A1 (en) * 2001-12-31 2003-07-24 Quark Biotech, Inc. Methods for identifying marker genes for cancer
US20030195431A1 (en) * 2002-04-10 2003-10-16 Sukhatme Vikas P. Observation of effects of body fluids on indicator cells for disease diagnosis
WO2003100000A2 (en) * 2002-05-24 2003-12-04 Tularik Inc. Amplification and overexpression of oncogenes
US20060281081A1 (en) * 2002-08-30 2006-12-14 Yusuke Nakamura Method of diagnosing colon and gastric cancers
EP1581652A4 (en) 2002-09-12 2008-02-13 Genenews Corp IDENTIFICATION OF SEQUENCES PARTICULAR USEFUL IN THE DIAGNOSIS AND IDENTIFICATION OF THERAPEUTIC TARGETS FOR OSTEO ARTHRITIS
US20060024692A1 (en) * 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
GB0227238D0 (en) * 2002-11-21 2002-12-31 Diagenic As Product and method
US7910550B2 (en) * 2004-04-16 2011-03-22 Stc.Unm Human kunitz-type inhibitor with enhanced antifibrinolytic activity
EP1809765A2 (en) * 2004-11-04 2007-07-25 Roche Diagnostics GmbH Classification of acute myeloid leukemia
US20070178503A1 (en) * 2005-12-19 2007-08-02 Feng Jiang In-situ genomic DNA chip for detection of cancer

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110444287B (zh) * 2011-04-29 2024-02-06 癌症预防和治疗有限公司 使用分类系统及其试剂盒识别和诊断肺部疾病的方法
CN110444287A (zh) * 2011-04-29 2019-11-12 癌症预防和治疗有限公司 使用分类系统及其试剂盒识别和诊断肺部疾病的方法
CN104822844B (zh) * 2012-10-01 2019-05-07 米伦纽姆医药公司 预测对抑制剂的反应的生物标记物和方法以及其用途
US10662477B2 (en) 2012-10-01 2020-05-26 Millennium Pharmaceuticals, Inc. Biomarkers and methods to predict response to inhibitors and uses thereof
CN104822844A (zh) * 2012-10-01 2015-08-05 米伦纽姆医药公司 预测对抑制剂的反应的生物标记物和方法以及其用途
CN111910002B (zh) * 2014-06-18 2024-04-12 东丽株式会社 食道癌的检测试剂盒或装置以及检测方法
CN111910002A (zh) * 2014-06-18 2020-11-10 东丽株式会社 食道癌的检测试剂盒或装置以及检测方法
CN109529018B (zh) * 2019-01-10 2021-11-30 南方医科大学南方医院 Atxn2l用于制备逆转胃癌奥沙利铂耐药的药物的用途
CN109529018A (zh) * 2019-01-10 2019-03-29 南方医科大学南方医院 Atxn2l用于制备逆转胃癌奥沙利铂耐药的药物的用途
CN113913436B (zh) * 2021-11-18 2023-09-29 天津市肿瘤医院(天津医科大学肿瘤医院) 逆转录转座基因l1-atp8b1及其作为肺鳞癌标志物的用途和治疗肺鳞癌的药物
CN113913436A (zh) * 2021-11-18 2022-01-11 天津市肿瘤医院(天津医科大学肿瘤医院) 逆转录转座基因l1-atp8b1及其作为肺鳞癌标志物的用途和治疗肺鳞癌的药物
CN115976212A (zh) * 2022-12-21 2023-04-18 四川大学华西医院 一种用于检测骨肿瘤诊断相关基因的探针库及试剂盒
CN115976212B (zh) * 2022-12-21 2024-06-11 四川大学华西医院 一种用于检测骨肿瘤诊断相关基因的探针库及试剂盒

Also Published As

Publication number Publication date
AU2005250219B2 (en) 2011-01-20
US20120295800A1 (en) 2012-11-22
ATE493511T1 (de) 2011-01-15
US20080026385A1 (en) 2008-01-31
GB0412301D0 (en) 2004-07-07
EP1766056A1 (en) 2007-03-28
ES2358910T3 (es) 2011-05-16
CA2568889A1 (en) 2005-12-15
US8105773B2 (en) 2012-01-31
NZ551797A (en) 2010-03-26
DK1766056T3 (da) 2011-03-14
JP5060945B2 (ja) 2012-10-31
DE602005025633D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2011-02-10
AU2005250219A1 (en) 2005-12-15
AP2006003862A0 (en) 2006-12-31
NO20065939L (no) 2007-02-08
ZA200610644B (en) 2008-07-30
JP2008501332A (ja) 2008-01-24
EP1766056B1 (en) 2010-12-29
SI1766056T1 (sl) 2011-05-31
WO2005118851A1 (en) 2005-12-15

Similar Documents

Publication Publication Date Title
CN101027410A (zh) 用于癌症诊断的寡核苷酸
Massoni-Badosa et al. An atlas of cells in the human tonsil
Jerby-Arnon et al. A cancer cell program promotes T cell exclusion and resistance to checkpoint blockade
Miragaia et al. Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation
WO2022109181A1 (en) Methods and compositions for analyzing immune infiltration in cancer stroma to predict clinical outcome
CN102859000A (zh) 诊断性基因表达平台
US20190100790A1 (en) Determination of notch pathway activity using unique combination of target genes
Bai et al. Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis
CN101454668A (zh) 癌症预测与预后以及监测癌症治疗的方法
CN102272325A (zh) 用于疾病诊断的分子表达谱的方法和组合物
CN109777872A (zh) 肺癌中的t细胞亚群及其特征基因
CN101124340A (zh) 血液淋巴细胞中子宫内膜异位症的分子诊断标志物的鉴定
Melloni et al. Risk of optic pathway glioma in neurofibromatosis type 1: No evidence of genotype–phenotype correlations in a large independent cohort
MacDonald et al. Synovial tissue myeloid dendritic cell subsets exhibit distinct tissue-niche localization and function in health and rheumatoid arthritis
Ozdemir et al. Unexpected rule-changes in a working memory task shape the firing of histologically identified delay-tuned neurons in the prefrontal cortex
CN102197143A (zh) 临床样品中的干扰素响应(iris)
CN101688247A (zh) 猫科动物骨关节炎的诊断方法和组合物
ZA200503797B (en) Product and method
Czerwiński et al. Variances in the expression of mRNAs and miRNAs related to the histaminergic system in endometrioid endometrial cancer
Zhao et al. Stereo-seq V2: Spatial mapping of total RNA on FFPE sections with high resolution
Lee et al. Use of omics data in fracture prediction; a scoping and systematic review in horses and humans
Nagel et al. Genomic aberrations generate fusion gene FOXK2:: TP63 and activate NFKB1 in cutaneous T-cell lymphoma
Vorperian et al. Cell types of origin in the cell free transcriptome in human health and disease
Zhou et al. ScRNA-seq and bulk RNA-seq identified NUPR1 as novel biomarkers related to CD4+ T cells infiltration for abdominal aortic aneurysm
CN101115848A (zh) 转录组微阵列技术及应用该技术的方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20070829